Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis

Recent studies reported that atorvastatin (ATOR) alleviated progression of experimental diabetic cardiomyopathy (DCM), possibly by protecting against apoptosis. However, the underlying mechanisms of this protective effect remain unclear. Therefore, our study investigated the role of the glycogen syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiao-min, Zuo, Guang-feng, Wu, Wen, Luo, Jie, Ye, Peng, Chen, Shao-liang, Hu, Zuo-ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112957/
https://www.ncbi.nlm.nih.gov/pubmed/27851811
http://dx.doi.org/10.1371/journal.pone.0166740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112957/
https://www.ncbi.nlm.nih.gov/pubmed/27851811
http://dx.doi.org/10.1371/journal.pone.0166740

Ejemplares similares